TrialWire™ AI-Match Platform was engaged by the sponsor at the recommendation of a regional CRO to rescue recruitment for this Alzheimer’s medication trial.

We were activated when recruitment slowed which was partly due to the inclusion/exclusion criteria as well as retention issues.

The campaign launched with a series of news article features (no EC approvals required) in national magazines and online media.

All patent engagement activity was funneled through the Platform so patients could be quickly online screened and connected to their nearest site for follow-up. AI-Match patient referrals achieved exceptional compliance and retention due to the “motivated patient” process which doesn’t rely on databases but finds people when they are actively researching online.

The study was fully recruited.